Welcome to our dedicated page for Ianthus news (Ticker: ITHUF), a resource for investors and traders seeking the latest updates and insights on Ianthus stock.
iAnthus Capital Holdings, Inc. (ITHUF) is a vertically integrated cannabis company that owns, operates and partners with regulated cannabis operations across the United States. Its news flow combines operational updates from its GrowHealthy retail platform in Florida with regular financial reporting as a public company.
Recent company announcements highlight the expansion of GrowHealthy dispensaries in Florida communities such as Jacksonville, Palm Harbor, Tamarac, Fort Myers and St. Petersburg. These openings emphasize increased patient access to medical cannabis, a focus on whole-plant wellness and premium genetics, and store designs tailored to local communities. News releases describe product menus that include flower, vapes, concentrates and other formats, along with in-store features intended to enhance the patient experience.
Alongside retail expansion, iAnthus regularly reports quarterly and annual financial results. The company issues press releases summarizing revenue, gross profit, net income or loss and other key metrics, and discusses non-GAAP measures such as EBITDA and Adjusted EBITDA with reconciliations to GAAP figures. These releases are often accompanied by SEC filings, including Forms 10-Q, 10-K and 8-K.
Investors and observers following ITHUF news can use this page to review updates on dispensary openings, brand deployment across markets, financial performance and shareholder meeting outcomes. The news stream provides context on how iAnthus is executing its strategy of building premium cannabis brands through a network of cultivation, production and retail operations in the United States.
iAnthus Capital Holdings (CSE: IAN, OTCPK: ITHUF) reported its financial results for the year ending December 31, 2022. Key figures include a 19.6% decrease in revenue to $163.2 million and a net loss of $449.4 million or $0.13 per share, compared to a loss of $77.5 million the previous year. The company’s gross profit fell 32.0% to $74.4 million with a gross margin of 45.6%. The fourth quarter saw revenue drop 21.3% to $37.6 million and an adjusted EBITDA loss of $1.0 million after a significant drop from $40.3 million in Q4 2021.
iAnthus Capital Holdings announced the resignation of board member Zachary Arrick, effective February 21, 2023. Arrick joined the board on June 24, 2022, following the company's recapitalization. Interim CEO Robert Galvin expressed gratitude for Arrick's contributions. According to the Investor Rights Agreement from June 24, 2022, the investor who nominated Arrick may designate a successor; however, no replacement has been appointed yet. iAnthus operates regulated cannabis operations across the U.S.
iAnthus Capital Holdings (OTCPK: ITHUF) has announced an amendment to its senior secured bridge notes due February 2, 2023. The maturity date has been extended to February 2, 2024, with an increased interest rate of 12% per annum. An amendment fee of 10% of the principal amount will also be payable at maturity. As of February 2, 2023, the outstanding principal amount is approximately US$14 million. This financial maneuver involves related-party lenders, including Gotham Green Partners and Senvest Management.
iAnthus Capital Holdings has appointed Philippe Faraut as Chief Financial Officer, effective immediately. Faraut brings over 20 years of financial management experience, previously serving as CFO at Irwin Naturals and holding senior positions at various financial firms. He replaces Julius Kalcevich, who held the CFO position since October 2016. The interim CEO, Robert Galvin, expressed excitement about Faraut's leadership as the company continues to grow in the cannabis sector across the U.S.
iAnthus Capital Holdings reported its financial results for Q3 2022, showing a revenue of $39.4 million, a 10% decline sequentially and a 20% decrease year-over-year. Gross profit fell to $16.2 million, a 18% reduction from Q2 2022, and 38% lower compared to Q3 2021. The gross margin stood at 41.1%, decreasing by 4.1% sequentially. The net loss was $22.0 million, significantly improved from the previous quarter's loss of $373.6 million. Adjusted EBITDA loss was $0.3 million, a decrease from $2.3 million in Q2 2022.
iAnthus Capital Holdings announced the resignation of Marco D'Attanasio from its board of directors, effective September 15, 2022. D'Attanasio joined in June 2022 following a recapitalization transaction. The company expressed gratitude for his contributions but has yet to appoint a successor nominee as per the Investor Rights Agreement. iAnthus operates cannabis facilities across the U.S. and is subject to potential operational disruptions from COVID-19. The company warns that its business and financial performance could be materially impacted by future public health emergencies.
iAnthus Capital Holdings reported its Q2 2022 financial results, revealing a revenue of $43.5 million, a sequential increase of 2% but down 20% year-over-year. The gross profit was $19.7 million, marking a 37% decline from the previous year. A significant net loss of $373.6 million was attributed mainly to a non-cash loss of $316.6 million from debt extinguishment during a recapitalization. Adjusted EBITDA stood at $2.3 million, down from $3.4 million in Q1 2022. iAnthus became a U.S. reporting company in February 2021, complying with GAAP reporting.
iAnthus Capital Holdings, which operates regulated cannabis businesses in the U.S., announced the results of its Annual General Meeting held on August 11, 2022. All proposed resolutions were approved by shareholders, including the election of six directors: Scott Cohen, Michelle Mathews-Spradlin, Kenneth W. Gilbert, Alexander Shoghi, Marco D'Attanasio, and Zachary Arrick. Additionally, Marcum LLP was appointed as the company's auditors. This meeting signifies strong shareholder support for the company's governance and operational direction.
iAnthus Capital Holdings has successfully closed its recapitalization transaction as of June 24, 2022. The transaction involved issuing a total of 6,072,579,705 Common Shares to secured lenders and holders of unsecured debentures, giving them a substantial 97.5% ownership stake. Existing shareholders hold only 2.75%. The company also restructured its debt, exchanging certain debentures for new secured and unsecured notes valued at $99,736,842 and $5,000,000, respectively. Additionally, $25,000,000 in new financing was secured for working capital. Changes to the board included resignations and new nominations.
On June 9, 2022, iAnthus Capital Holdings announced that the Massachusetts Cannabis Control Commission approved the change of ownership for its subsidiary, Mayflower Medicinals, tied to a recapitalization transaction. This approval follows earlier permissions granted on June 17, 2021, and August 12, 2021. With only two regulatory approvals pending in New Jersey and New York, iAnthus expects to finalize the recapitalization soon. The company operates licensed cannabis businesses across the U.S.